Swedish cancer registry tracks 1,500 patients on common treatment
NCT ID NCT04654208
Summary
This study aims to understand how Swedish patients with advanced breast cancer are using the drug palbociclib in everyday medical care. It will observe about 1,500 adult patients who have been prescribed this medication, tracking how long they stay on treatment and their health outcomes. The goal is to gather real-world information on treatment patterns and patient results, not to test a new therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BREAST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Sweden
Sollentuna, Sweden
Conditions
Explore the condition pages connected to this study.